Activation of O~2~ is important in biology because O~2~, despite its high abundance in the Earth's atmosphere and high oxidizing power, is kinetically inert. A prominent example of O~2~ activation is aerobic respiration, in which the oxidizing potential of O~2~ is used to generate a proton gradient, driving synthesis of adenosine triphosphate, the energy source for most biological processes. This reaction is efficiently catalyzed by terminal oxidases, e.g., heme-copper oxidases (HCOs) containing a heme and Cu~B~ center^[@ref1]^ and cytochrome (cyt) *bd*-oxygen reductases with only hemes at the active site.^[@ref2]^ While these enzymes and their model systems have been extensively studied and mechanisms have been proposed,^[@ref1]−[@ref3]^ an understanding of structural features responsible for O~2~ activation is still being sought. For example, while a number reports have elucidated H-bond networks in the channels *leading to* the Cu~B~ site in HCOs,^[@ref1],[@cit3a],[@cit3b]^ experimental support for structural features, e.g., a putative H-bond network involving H~2~O *within* the Cu~B~ site, proposed by computational modeling,^[@ref4]^ remains elusive.

To elucidate structural features responsible for efficient O~2~ activation, biochemical and biophysical studies of the oxidases and related enzymes have identified potentially important amino acid residues in the reaction, which has been confirmed by loss of activity in site-directed mutagenesis (SDM) studies.^[@ref1],[@cit3a],[@cit3b],[@ref5],[@ref6]^ However, these mutations often cause structural perturbations in addition to those directly being investigated, which may cause loss of function. Moreover, SDM studies reveal only necessary, but not minimally sufficient structural features for function. To overcome this limitation, synthetic models of native enzymes have been prepared, and their studies have offered deeper insights into the structural features responsible for oxidase activity.^[@cit3g],[@cit3h],[@ref7]^

As a complementary approach to the studies of native enzymes and their synthetic models, use of small designed metalloproteins and -peptides has shown remarkable success.^[@ref8]^ For example, we have employed a "biosynthetic modeling" approach, based on a small natural protein scaffold, to gain fundamental understanding of sufficient features conferring oxidase activity, i.e., 4e^--^ reduction of O~2~ to H~2~O.^[@cit8a],[@ref9]^ In contrast to native enzymes, such as HCOs, which are membrane proteins that are not easy to purify to homogeneity with high yields and contain other accessory metal sites that can complicate spectroscopic studies, biosynthetic models are simpler to synthesize and contain only the metal-binding site central to the enzymatic activity. While most HCO models use organic molecules as ligands, our biosynthetic approach uses small, stable, and well-characterized proteins, such as sperm whale myoglobin (Mb), as the scaffold. Thanks to recent advances in biology, biosynthetic models of complex metal-binding sites can be prepared more easily and with higher yields than using organic molecule ligands. Furthermore, the structurally rigid scaffold protein allows defining long-range non-covalent interactions and probing their roles more precisely. Using this approach, we previously reported the design of an HCO mimic by introducing two His and one Tyr residues in the active site of wild-type (WT) Mb (named F33Y-Cu~B~Mb) and found that, unlike WTMb, which only binds O~2~ reversibly, this protein achieves O~2~ reduction to H~2~O with \>500 turnovers.^[@cit9d]^ Thus, this minimal functional mimic, much simpler than native oxidases while still functioning under physiological conditions, provides a platform for elucidating structural features responsible for O~2~ reduction that bridges the gap between native enzymes and small molecular mimics of native enzymes.

We hypothesize that F33Y-Cu~B~Mb operates by heterolytic O--O bond cleavage ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}), analogous to the accepted mechanism for native oxidases and monooxygenases, but the detailed structural features and interactions that promote this reaction in F33Y-Cu~B~Mb are still unclear. Here we use cryogenic EPR spectroscopy and high-resolution X-ray crystallography to show that an extensive H-bond network involving H~2~O molecules exists in the active site of F33Y-Cu~B~Mb and plays an important role in facilitating proton delivery to the oxygen and activating it for reduction, thus, imparting oxidase activity.

![Proposed Mechanism of O~2~ Reduction by F33Y-Cu~B~Mb in Comparison with WTMb](ja-2015-12004e_0001){#sch1}

EPR has been widely used to probe the environment of O~2~-activating iron enzymes.^[@ref10]^ Although oxy-heme is an electronically closed-shell system with no EPR signal, EPR spectroscopy has been used to offer insight into the properties of oxy-heme, e.g., its interactions with nearby residues and its intermediates upon reduction, by a method called cryoreduction.^[@ref11]^ Briefly, the oxy-heme protein, trapped at 77 K, is exposed to γ-radiation, releasing "free" electrons into the sample matrix to efficiently reduce EPR-silent oxy-heme into EPR-active peroxo-heme. Because cryogenic trapping suppresses thermal relaxation and equilibration of the protein and its active site, EPR spectra of the resulting sample, maintained at 77 K, provide valuable structural information on the oxy-heme precursor ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@cit10a],[@cit10f]−[@cit10l],[@ref11]^ Furthermore, the peroxo-heme products are intermediates along the pathway of O~2~ reduction, and subsequent decay, achieved by stepwise warming of the samples, followed by rapid recooling to 77 K after each step to trap intermediates-a procedure called annealing, provides further insight into the reaction ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@cit10a],[@ref11],[@ref12]^ As a result, EPR spectroscopy in combination with cryoreduction and annealing has been used over the past two decades to probe the structure and interactions of O~2~ in many heme proteins, including myoglobins and monooxygenases.^[@cit10a],[@cit10f]−[@cit10q],[@ref11],[@ref12]^ Because WTMb, the scaffold for F33Y-Cu~B~Mb, was among the first and most studied proteins by the above method, the abundance of results facilitates understanding of the latter by direct comparison. In this study, F33Y-Cu~B~Mb contained heme but no metal ion in the Cu~B~ site, because a previous report showed that this protein exhibits high oxidase activity without a metal ion at Cu~B~,^[@cit9d]^ mimicking cyt *bd*-oxygen reductases, which lack this site.^[@ref2]^

![Formation and Trapping of (Hydro)peroxo Intermediates by Cryoreduction](ja-2015-12004e_0002){#sch2}

[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} shows EPR spectra of oxy-WTMb and oxy-F33Y-Cu~B~Mb cryoreduced at 77 K, obtained under the same conditions. The WTMb spectrum shows the signal from a single species with *g* = \[2.22, 2.13, 1.96\] (see [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf) for spectra at other temperatures) whose EPR parameters ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) identify it as a ferric-peroxo state, with the peroxo ligand H-bonded to the distal His-64.^[@cit10f]−[@cit10i],[@ref11]^ In contrast, the cryoreduced oxy-F33Y-Cu~B~Mb exhibits two rhombic EPR signals ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, [S1, and S2](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)). The first, with *g* = \[2.24, 2.13, 1.95\], is similar to that of the ferric-peroxo species in WTMb. The second, more rhombic EPR signal, has *g* = \[2.29, 2.17, 1.96\], in the range characteristic of ferric-hydroperoxo intermediates.^[@cit10a],[@cit10h],[@cit10k]−[@cit10m]^ This assignment is supported by ^1^H ENDOR measurements ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)), where the *g*~max~ = 2.24 species has been removed by annealing, showing a maximum proton coupling of ∼9.5 MHz. Ferric-peroxo intermediates show strongly coupled exchangeable proton signals with *A*~max~ ≈ 14--18 MHz,^[@cit10a],[@cit10i],[@cit10o]^ while hydroperoxo- exhibit a smaller coupling, *A*~max~ ≤ 13 MHz.^[@cit10j],[@cit10k],[@cit10q]^ The absence of signal with *A*~max~ \> 13 MHz confirms that the more rhombic species observed in F33Y-Cu~B~Mb is hydroperoxo, not peroxo.

![EPR spectra of oxy-WTMb and oxy-F33Y Cu~B~Mb after radiolytic reduction with a ∼3 Mrad dose of γ radiation from ^60^Co, and after subsequent stepwise annealing for 1 min at indicated temperatures (sharp signal marked by asterisk is due to radiolytically generated H-atoms at 77 K in quartz EPR tube).](ja-2015-12004e_0005){#fig1}

###### *g*-Values of Cryoreduced Oxy-ferrous Myoglobins

  protein        *g*~1~                                        *g*~2~   *g*~3~   
  -------------- --------------------------------------------- -------- -------- -------
  WTMb           peroxo                                        2.22     2.12     1.965
                 hydroperoxo[a](#t1fn2){ref-type="table-fn"}   2.32     2.18     1.943
  F33y Cu~B~Mb   peroxo                                        2.24     2.13     1.964
                 hydroperoxo[b](#t1fn1){ref-type="table-fn"}   2.29     2.16     1.950
                 hydroperoxo[a](#t1fn2){ref-type="table-fn"}   2.34     2.19     1.937

Hydroperoxo product formed upon annealing.

Primary hydroperoxo product formed at 77 K.

To gain further insight into O~2~ reduction by F33Y-Cu~B~Mb, we monitored the decay of the above cryoreduced species by annealing. As previously reported, annealing the cryoreduced oxy-WTMb at 190 K converts the peroxo signal with *g*~max~ = 2.22 to the more rhombic EPR signal of a ferric-hydroperoxo intermediate, with *g* = \[2.32, 2.18, 1.93\] ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [S1](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)), through protonation of the peroxo moiety.^[@ref13]^ Upon annealing of cryoreduced oxy-F33Y-Cu~B~Mb at 173--175 K for at least 1 min, a signal with *g* = \[2.34, 2.19, 1.94\] begins to appear and continues to grow in at 190 K ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, [S1, and S2](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)). These EPR parameters are very similar to those of ferric-hydroperoxo-WTMb. Appearance of this signal during annealing is interpreted to arise from both protonation of the ferric-peroxo centers with *g*~max~ = 2.24 to form ferric-hydroperoxo, and relaxation/repositioning of the hydroperoxo ligand of the *g*~max~ = 2.29 species of the heme iron ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

Based on the known reactivity of the (hydro)peroxo-hemes, these intermediates are expected to thermally decompose to compound II (CpdII), a ferryl species that is EPR silent. Consistent with this expectation, further annealing both samples at 210 and 220 K ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [S1](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)) results in obvious decay of the (hydro)peroxo signals to an EPR-silent state. It has been shown that further cryoreduction of the EPR-silent CpdII (Fe(IV)=O^2--^) at 77 K generates a low-spin rhombic EPR signal from the Fe(III)--O^2--^ or Fe(III)--OH^--^ species, depending on the protonation state of ferryl precursor. Subsequent cryoreduction of the EPR-silent species in WTMb resulted in a signal with *g* = \[2.43, −, 1.93\] ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)), characteristic of Fe(III)--O^2--^ (ferric oxo) species observed in cryoreduced CpdII (*g* = \[2.43, 2.12, 1.93\]),^[@cit12d]^ confirming the EPR-silent state arising after annealing of (hydro)peroxo-WTMb as the Fe(IV)=O^2--^ CpdII. A minor signal with *g* = \[2.52, −, 1.90\] ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)) was also observed, previously assigned as protonated ferric-oxo, i.e., ferric-hydroxo (Fe(III)--OH^--^).^[@cit12d]^ In the case of F33Y-Cu~B~Mb, further cryoreduction of the EPR-silent annealed species yielded a dominant EPR signal with *g* = \[2.52, 2.15, 1.90\] ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)), likewise assigned as ferric-hydroxo. This result supports the hypothesis that the hydroperoxo-F33Y-Cu~B~Mb converts to CpdII. This assignment is confirmed by comparison with the same signals observed in cryoreduced samples of CpdII, generated in both proteins by reaction with H~2~O~2~ at 21--25 °C ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)).

Observation of two distinct signals in cryoreduced oxy-F33Y-Cu~B~Mb at 77 K suggests the presence of two structural states of the oxy-ferrous precursor. The peroxo signal with *g*~max~ = 2.24 is nearly identical to the signal observed in WTMb and well within the range of those of other oxygen-binding proteins such as hemoglobin,^[@cit10h],[@cit10i]^ suggesting that the oxy-ferrous population leading to this state has similar interactions and behaves in a similar manner. On the other hand, the observation of a hydroperoxo species with *g*~max~ = 2.29 at 77 K requires a configuration in which the oxygen can be easily protonated at 77 K ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The observation of protonated Fe(III)--OH^--^ in F33Y-Cu~B~Mb upon subsequent cryoreduction of annealed species provides further support for the facile protonation of intermediates. Previous cryoreduction studies of a variety of oxy-heme proteins^[@cit10a],[@cit10j]−[@cit10o],[@cit12a],[@cit12c]^ showed that proton transfer to a cryoreduced oxy-heme at 77 K requires the presence of an extended H-bonded proton delivery network in the oxy-ferrous protein that includes protic residues and at least one ordered H~2~O molecule H-bonded to the terminal O-atom of the O~2~ ligand. Based on these observations, we hypothesized that the F33Y-Cu~B~Mb may contain a similar H-bond network for faster proton delivery to the oxy-heme than in WTMb. To test this, we obtained the crystal structure of oxy-F33Y-Cu~B~Mb.

The oxy-F33Y-Cu~B~Mb crystal was prepared by soaking ferric-Mb crystals in dithionite, followed by exposure to O~2~,^[@ref14]^ and the oxy state was confirmed by single-crystal UV/vis spectroscopy before diffraction ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf)). The structure, refined at 1.27 Å resolution, is compared with the structure of oxy-WTMb in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}.^[@ref15]^ An omit-map showing the electron density of the oxygen ligand is shown in [Figure S6](http://pubs.acs.org/doi/suppl/10.1021/jacs.5b12004/suppl_file/ja5b12004_si_001.pdf). Due to reduced oxygen affinity of F33Y-Cu~B~Mb, refinement of this structure yielded an incomplete occupancy for the oxygen ligand, but it nevertheless supports the above interpretation of the EPR data. As suggested by the EPR results, an extended H-bond network involving two H~2~O molecules is observed, with W1 stabilized by H-bonds with the engineered His43 and Tyr33 residues, and W2 stabilized by H-bonds to W1 and the engineered His29 ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Together, this H-bond network links the designed residues and the distal O-atom of bound O--O. As a result of these changes in the active-site pocket, the O--O in F33Y-Cu~B~Mb is rotated from that in WTMb by ∼13° about the Fe--O bond, apparently to maximize its ability to accept H-bonds from His64 and W2. Such an interaction of the oxygen with the W2 is expected to enable the facile protonation, by W2, of the peroxo intermediate formed on cryoreduction at 77 K, yielding the hydroperoxo observed by the cryogenic EPR.

![Crystal structure of oxy-F33Y-Cu~B~Mb determined at 1.27 Å resolution (PDB: 5HAV), compared with that of oxy-WTMb (1A6M).^[@ref16]^](ja-2015-12004e_0006){#fig2}

Given the spectroscopic and crystallographic evidence for an H-bond network that interacts with the O~2~ in oxy-F33Y-Cu~B~Mb, and its absence in oxy-WTMb, we conclude that this H-bond network is the important structural feature that transforms WTMb, a protein that can only bind O~2~ reversibly, into F33Y-Cu~B~Mb, a protein that can activate O~2~ and reduce it to H~2~O. We propose that this activation is achieved by polarization of the O--O bond by the H-bonded H~2~O, allowing facile reduction and protonation of the oxygen and intermediates. While H-bond networks involving water have been observed in native heme enzymes such as cyt P450^[@cit10l],[@cit10m],[@ref17]^ and a similar network has been proposed to occur in HCOs-based computational and isotope studies,^[@ref4]^ design of metalloenzymes incorporating this important structural feature has been difficult to perform and confirm. The combination of cryoreduction EPR spectroscopy and high-resolution crystallography presented in this work provides a clear example of the importance of H-bond networks involving water in conferring activity to designed metalloenzymes. We believe this structural feature will be critical to enhancing the future success of high-activity metalloenzyme design.
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